Veysel Ersan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Veysel Ersan has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Sezai Yilmaz
Liver Transplant Institute, İnonu University, Malatya, Türkiye
11 shared publications - Cuneyt Kayaalp
Department of General Surgery, Faculty of Medicine, Istanbul Atlas University, Istanbul 34403, Turkey
9 shared publications - Volkan Ince
Department of Surgery, Liver Transplantation Institute, Inonu University, Malatya 44280, Türkiye
9 shared publications - Abuzer Dirican
Department of General Surgery, Istanbul Aydin University, Istanbul, Türkiye
7 shared publications - Burak Isik
Department of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya 44280, Turkey
5 shared publications S. Yilmaz
Department of Surgery, Liver Transplantation Institute, Inonu University, Malatya, Turkey
5 shared publications
Latest Publications
- 25 August 2026
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 49 (11) , 2509-2512
Dedicated Venous Stent-in-Stent Reconstruction for Graft Regeneration-Induced Hepatic Venous Outflow Obstruction After Living Donor Liver Transplantation
- 25 August 2026
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 49 (11) , 2509-2512
Dedicated Venous Stent-in-Stent Reconstruction for Graft Regeneration-Induced Hepatic Venous Outflow Obstruction After Living Donor Liver Transplantation
- Open Access
- 27 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (11) , 1635
Monitoring Inflammatory Markers and Anti-α-Gal Antibodies in Liver Transplant Recipients: Implications for Infection and Rejection
Objective: Living donor liver transplantation is a multifactorial process, and non-invasive serological parameters that may provide information about graft and patient status are still under investigation. However, time-dependent factors such as infection and rejection are often overlooked. Therefore, this study aimed to investigate anti-α-Gal1,3 levels and the expression of inflammatory and anti-inflammatory genes in peripheral blood samples obtained from 26 liver transplant patients before transplantation and at the first and sixth months post-transplantation. Additionally, 15 healthy volunteers were included as a control group, and patients were followed for two years to evaluate graft rejection. Method: A total of 26 living-donor liver transplant recipients and 15 healthy volunteers were included in the study. Peripheral blood samples were collected from patients before transplantation and at the first and sixth months after transplantation. Gene expression levels of IL2, IL4, IL6, IL10, TNF, IFNG, FOXP3, TREM1, CD14, and HLAG5 were analyzed by qRT-PCR, while anti-α-Gal IgM and IgG levels were measured by ELISA. In addition, biochemical parameters and microbiological culture analyses were evaluated, and bacterial identification was confirmed by MALDI-TOF MS when necessary. Analyses were performed across three time points with respect to infection status and graft rejection. Results: While the expression of IFNG, IL2, and HLAG5 significantly increased 6 months after transplantation, IL10 expression decreased significantly. In patients without rejection, IFNG expression increased significantly and IL10 expression decreased significantly at the sixth month. Microbiological evaluation showed that infections were more frequent, particularly during the first three months after transplantation. While anti-α-Gal IgG levels did not differ according to infection status, IgM levels decreased significantly at the sixth month, and this decline was associated with a reduced infection burden. Conclusions: In conclusion, IFNG and IL10 gene expression levels may serve as important indicators for predicting rejection after liver transplantation, whereas anti-α-Gal IgM levels may provide useful guidance in monitoring infection.
- 27 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (11) , 1635
Open AccessMonitoring Inflammatory Markers and Anti-α-Gal Antibodies in Liver Transplant Recipients: Implications for Infection and Rejection
Objective: Living donor liver transplantation is a multifactorial process, and non-invasive serological parameters that may provide information about graft and patient status are still under investigation. However, time-dependent factors such as infection and rejection are often overlooked. Therefore, this study aimed to investigate anti-α-Gal1,3 levels and the expression of inflammatory and anti-inflammatory genes in peripheral blood samples obtained from 26 liver transplant patients before transplantation and at the first and sixth months post-transplantation. Additionally, 15 healthy volunteers were included as a control group, and patients were followed for two years to evaluate graft rejection. Method: A total of 26 living-donor liver transplant recipients and 15 healthy volunteers were included in the study. Peripheral blood samples were collected from patients before transplantation and at the first and sixth months after transplantation. Gene expression levels of IL2, IL4, IL6, IL10, TNF, IFNG, FOXP3, TREM1, CD14, and HLAG5 were analyzed by qRT-PCR, while anti-α-Gal IgM and IgG levels were measured by ELISA. In addition, biochemical parameters and microbiological culture analyses were evaluated, and bacterial identification was confirmed by MALDI-TOF MS when necessary. Analyses were performed across three time points with respect to infection status and graft rejection. Results: While the expression of IFNG, IL2, and HLAG5 significantly increased 6 months after transplantation, IL10 expression decreased significantly. In patients without rejection, IFNG expression increased significantly and IL10 expression decreased significantly at the sixth month. Microbiological evaluation showed that infections were more frequent, particularly during the first three months after transplantation. While anti-α-Gal IgG levels did not differ according to infection status, IgM levels decreased significantly at the sixth month, and this decline was associated with a reduced infection burden. Conclusions: In conclusion, IFNG and IL10 gene expression levels may serve as important indicators for predicting rejection after liver transplantation, whereas anti-α-Gal IgM levels may provide useful guidance in monitoring infection.
- 14 September 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (9) , 1808-1811
Living Donor Liver Transplantation in Patients With Portal Vein Thrombosis: A Single-Center Experience
- 14 September 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (9) , 1808-1811
Living Donor Liver Transplantation in Patients With Portal Vein Thrombosis: A Single-Center Experience
- 16 July 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (9) , 1777-1780
Effectiveness of Variceal Band Application in Preventing Bile Leakage Associated With Trans-Cystic Feeding Catheter in Living-Donor Liver Transplantation
- 16 July 2025
- Published by Elsevier in Transplantation Proceedings
- Vol. 57 (9) , 1777-1780
Effectiveness of Variceal Band Application in Preventing Bile Leakage Associated With Trans-Cystic Feeding Catheter in Living-Donor Liver Transplantation
- Open Access
- 1 January 2025
- Published by Kare Publishing in Lokman Hekim Health Sciences
- Vol. 5 (1) , 1-2
Infections in Liver Transplant Patients and the Influence of Infectious Diseases Specialists on the Entire Process
Liver Transplant Patients and the Influence of Infectious Diseases Specialists on the Entire Process Karaciğer Nakli Hastalarında Enfeksiyonlar ve Enfeksiyon Hastalıkları Uzmanlarının Süreçteki Etkisi L iver transplantation is a life-saving procedure for patients with end-stage liver disease, yet post-transplant infections remain a significant challenge. The review article by Bayındır et al. [1] provides a detailed and well-structured discussion on this topic, effectively highlighting the critical role of Infectious Diseases (ID) specialists throughout the transplant process. This editorial further emphasizes the relevance of their analysis, reinforcing the importance of infection control, antimicrobial stewardship, and ongoing post-transplant care.
- 1 January 2025
- Published by Kare Publishing in Lokman Hekim Health Sciences
- Vol. 5 (1) , 1-2
Open AccessInfections in Liver Transplant Patients and the Influence of Infectious Diseases Specialists on the Entire Process
Liver Transplant Patients and the Influence of Infectious Diseases Specialists on the Entire Process Karaciğer Nakli Hastalarında Enfeksiyonlar ve Enfeksiyon Hastalıkları Uzmanlarının Süreçteki Etkisi L iver transplantation is a life-saving procedure for patients with end-stage liver disease, yet post-transplant infections remain a significant challenge. The review article by Bayındır et al. [1] provides a detailed and well-structured discussion on this topic, effectively highlighting the critical role of Infectious Diseases (ID) specialists throughout the transplant process. This editorial further emphasizes the relevance of their analysis, reinforcing the importance of infection control, antimicrobial stewardship, and ongoing post-transplant care.
- 6 June 2024
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 48 (4) , 261-273
Chronic liver fibrosis induction in aging causes significant ultra-structural deterioration in liver and alteration on immune response gene expressions in liver-spleen axis
The relationship between damage to the liver and spleen by aging and the immune response status in these two organs, which are anatomically and immunologically interconnected, is unknown. The authors investigated the histopathological, ultrastructural, and immunological effects of aging in young and aged fibrotic mice by using an experimental model. Four groups were planned, with 10 mice in each experimental group. The levels of fibrosis and ultrastructural destruction in the liver were determined by alpha-SMA staining and TEM analysis. Expression levels of immunity genes (Il2, Il4, Il6, Il10, Il12, Il17, Tnf, Ifng, Tgfb1, Gata3, Rorc, Tbx21, Foxp3, Ccl2, Ccr2, Cxcr3, Pf4, Cxcl10) were carried out by qRT-PCR. While structural disorders were detected in the mitochondria of aged healthy group, cellular destruction in the fibrosis-induced elderly group was at a dramatic level. Fibrosis induction in aged mice caused an elevation in the expression of chemokines (CCl2, CXCL10, CCR2) and cytokine (IL-17a) genes that induce autoinflammatory response in the liver. Unlike the cellular pathology and genes activated in fibrosis in youth and the natural occurrence of fibrosis with aging, induction of fibrosis during aging causes deterioration in the liver and expression of genes responsible for autoimmunity in both the liver and spleen.
- 6 June 2024
- Published by Taylor & Francis in Ultrastructural Pathology
- Vol. 48 (4) , 261-273
Chronic liver fibrosis induction in aging causes significant ultra-structural deterioration in liver and alteration on immune response gene expressions in liver-spleen axis
The relationship between damage to the liver and spleen by aging and the immune response status in these two organs, which are anatomically and immunologically interconnected, is unknown. The authors investigated the histopathological, ultrastructural, and immunological effects of aging in young and aged fibrotic mice by using an experimental model. Four groups were planned, with 10 mice in each experimental group. The levels of fibrosis and ultrastructural destruction in the liver were determined by alpha-SMA staining and TEM analysis. Expression levels of immunity genes (Il2, Il4, Il6, Il10, Il12, Il17, Tnf, Ifng, Tgfb1, Gata3, Rorc, Tbx21, Foxp3, Ccl2, Ccr2, Cxcr3, Pf4, Cxcl10) were carried out by qRT-PCR. While structural disorders were detected in the mitochondria of aged healthy group, cellular destruction in the fibrosis-induced elderly group was at a dramatic level. Fibrosis induction in aged mice caused an elevation in the expression of chemokines (CCl2, CXCL10, CCR2) and cytokine (IL-17a) genes that induce autoinflammatory response in the liver. Unlike the cellular pathology and genes activated in fibrosis in youth and the natural occurrence of fibrosis with aging, induction of fibrosis during aging causes deterioration in the liver and expression of genes responsible for autoimmunity in both the liver and spleen.
- Open Access
- 26 September 2023
- Published by Pamukkale University in Pamukkale Medical Journal
Yüksek vücut kitle indeksi, sağ lob canlı donörden karaciğer nakli alıcılarında postoperatif kanama ve safra komplikasyon oranlarını artıran bir faktör mü?
Purpose: High Body Mass Index emerges as an important perioperative and postoperative risk factor for liver transplantation We aimed to examine the effect of increased BMI on perioperative follow-up parameters and per-postoperative complications in liver transplant recipients. Materials and methods: One hundred and seventy-two patients who underwent living-donor liver transplantation for end stage liver cirrhosis were included in the study. Whether there was a difference between cold ischemia time, operation time, blood product transfusion rates, hospital, biliary complications, hepatic vein thrombosis, portal vein thrombosis, NASH etiology, postoperative hemorrhage, sepsis, and primary graft dysfunction were analyzed statistically in terms of those with a BMI of 25 and above and those below 25. Results: Anhepatic phase duration (p=0.047) and cold ischemia duration (p=0.009) were statistically longer in patients with BMI >25. Conclusion: Prolonged anhepatic phase and cold ischemia times may be important in terms of the effect of increased BMI on postoperative graft survival.
- 26 September 2023
- Published by Pamukkale University in Pamukkale Medical Journal
Open AccessYüksek vücut kitle indeksi, sağ lob canlı donörden karaciğer nakli alıcılarında postoperatif kanama ve safra komplikasyon oranlarını artıran bir faktör mü?
Purpose: High Body Mass Index emerges as an important perioperative and postoperative risk factor for liver transplantation We aimed to examine the effect of increased BMI on perioperative follow-up parameters and per-postoperative complications in liver transplant recipients. Materials and methods: One hundred and seventy-two patients who underwent living-donor liver transplantation for end stage liver cirrhosis were included in the study. Whether there was a difference between cold ischemia time, operation time, blood product transfusion rates, hospital, biliary complications, hepatic vein thrombosis, portal vein thrombosis, NASH etiology, postoperative hemorrhage, sepsis, and primary graft dysfunction were analyzed statistically in terms of those with a BMI of 25 and above and those below 25. Results: Anhepatic phase duration (p=0.047) and cold ischemia duration (p=0.009) were statistically longer in patients with BMI >25. Conclusion: Prolonged anhepatic phase and cold ischemia times may be important in terms of the effect of increased BMI on postoperative graft survival.
- Open Access
- 23 September 2023
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 30 (3) , 508-513
HEPATITIS B SERO-PREVALENCE AND AFFECTING FACTORS IN OPERATING ROOM AND LABORATORY WORKERS AT TURGUT ÖZAL MEDICAL CENTER IN 2017
Amaç: Hepatit B virüsü (HBV) insan sağlığını tehdit eden önemli bir sağlık sorunudur. Sağlık çalışanlarında kan ve kan ürünleriyle bulaşan HBV ile enfekte olma riski genel topluma göre daha yüksektir. Bu çalışmada XXX ameliyathane ve laboratuvar çalışanlarındaki HBV sero-prevalansını (HBsAg ve Anti-HBs) ve bu prevalansı etkileyen faktörleri incelemeyi amaçladık. Gereç ve Yöntem: XXX'de ameliyathane ve laboratuvarda çalışan 180 sağlık çalışanının 2017 yılı içerisindeki HBsAg ve Anti-HBs sonuçları kaydedildi. Hazırlanan bilgi formundaki sorulara ait cevaplar (cinsiyet, öğrenim durumu, medeni durumu, meslek, çalıştığı yer, doğduğu yer, çalıştığı süre, ailede HBV seropozitifliği, kan transfüzyonu) burada çalışanlarla yüz yüze görüşülerek elde edildi. İstatistiksel veriler ise SPSS 18 programı kullanılarak değerlendirildi. Bulgular: 180 adet sağlık personeli değerlendirildi. Bunlardan 81’i (%45) erkek ve 99’u (%55) kadın idi. Erkeklerde yaş ortalaması 34,5±7,8 iken, kadınlarda 35,3±6,5 idi. Çalışmaya katılan personelin 71’i (39,7%) hemşire, 57’si (31,8%) anestezi teknisyeni, 35’i (19,6%) biyolog/kimyager ve 16’sı (8,9%) idari personeldi. Sadece 3 çalışanda HBsAg pozitif olduğundan çalışanların değişkenleri ile Anti-HBs pozitifliği (bağışıklık) arasında istatistiksel ilişki değerlendirildi. Sadece Anti-HBs pozitifliği (n=152, %85,4) ile çalışılan yer arasında istatistiksel olarak anlamlı (p=0,048) bir ilişki saptandı. Sonuç: Çalışanlarda Anti-HBs pozitiflik oranı %85,4 idi. HBs antikor pozitifliğiyle çalışılan yer arasında istatistiksel anlamlı bir ilişki vardı. Bu da laboratuvar çalışanlarında bağışıklık oranının daha yüksek olmasından kaynaklanıyordu. HBV için risk altında olan sağlık personelinin bu virüs açısından taranması ve HBV’ye karşı bağışık olmayanların aşılanması gerekmektedir.
- 23 September 2023
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 30 (3) , 508-513
Open AccessHEPATITIS B SERO-PREVALENCE AND AFFECTING FACTORS IN OPERATING ROOM AND LABORATORY WORKERS AT TURGUT ÖZAL MEDICAL CENTER IN 2017
Amaç: Hepatit B virüsü (HBV) insan sağlığını tehdit eden önemli bir sağlık sorunudur. Sağlık çalışanlarında kan ve kan ürünleriyle bulaşan HBV ile enfekte olma riski genel topluma göre daha yüksektir. Bu çalışmada XXX ameliyathane ve laboratuvar çalışanlarındaki HBV sero-prevalansını (HBsAg ve Anti-HBs) ve bu prevalansı etkileyen faktörleri incelemeyi amaçladık. Gereç ve Yöntem: XXX'de ameliyathane ve laboratuvarda çalışan 180 sağlık çalışanının 2017 yılı içerisindeki HBsAg ve Anti-HBs sonuçları kaydedildi. Hazırlanan bilgi formundaki sorulara ait cevaplar (cinsiyet, öğrenim durumu, medeni durumu, meslek, çalıştığı yer, doğduğu yer, çalıştığı süre, ailede HBV seropozitifliği, kan transfüzyonu) burada çalışanlarla yüz yüze görüşülerek elde edildi. İstatistiksel veriler ise SPSS 18 programı kullanılarak değerlendirildi. Bulgular: 180 adet sağlık personeli değerlendirildi. Bunlardan 81’i (%45) erkek ve 99’u (%55) kadın idi. Erkeklerde yaş ortalaması 34,5±7,8 iken, kadınlarda 35,3±6,5 idi. Çalışmaya katılan personelin 71’i (39,7%) hemşire, 57’si (31,8%) anestezi teknisyeni, 35’i (19,6%) biyolog/kimyager ve 16’sı (8,9%) idari personeldi. Sadece 3 çalışanda HBsAg pozitif olduğundan çalışanların değişkenleri ile Anti-HBs pozitifliği (bağışıklık) arasında istatistiksel ilişki değerlendirildi. Sadece Anti-HBs pozitifliği (n=152, %85,4) ile çalışılan yer arasında istatistiksel olarak anlamlı (p=0,048) bir ilişki saptandı. Sonuç: Çalışanlarda Anti-HBs pozitiflik oranı %85,4 idi. HBs antikor pozitifliğiyle çalışılan yer arasında istatistiksel anlamlı bir ilişki vardı. Bu da laboratuvar çalışanlarında bağışıklık oranının daha yüksek olmasından kaynaklanıyordu. HBV için risk altında olan sağlık personelinin bu virüs açısından taranması ve HBV’ye karşı bağışık olmayanların aşılanması gerekmektedir.
- 14 September 2022
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 45 (1) , 102-113
Is hepatitis-B immunization effective during chronic liver fibrosis? Investigation of secretory and cellular immune responses on an experimental model
Adults with end-stage of chronic liver diseases have lower antibody titers after hepatitis-B vaccination. We have less amount of knowledge about the effect of non-viral cause chronic liver fibrosis...
- 14 September 2022
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 45 (1) , 102-113
Is hepatitis-B immunization effective during chronic liver fibrosis? Investigation of secretory and cellular immune responses on an experimental model
Adults with end-stage of chronic liver diseases have lower antibody titers after hepatitis-B vaccination. We have less amount of knowledge about the effect of non-viral cause chronic liver fibrosis...
- 23 May 2022
- Published by Taylor & Francis in Acta Chirurgica Belgica
- Vol. 123 (5) , 1-8
Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinoma
Current standard treatment for perihilar cholangiocarcinoma (pCCA) is surgical resection. Bismuth-Corlette (BC) type IV pCCA is accepted as an unresectable disease. In the present study, the results of non-transplant surgical approaches in patients with BC type IV pCCA were examined. Medical records of consecutive patients with BC type IV pCCA between 2010 and 2021 were retrospectively reviewed. Patients were subdivided according to operation type. Postoperative survival rates were compared. Hemihepatectomy with caudate lobe and extrahepatic bile duct (EHBD) resection was performed in 15 patients and only EHBD resection was performed in 10 patients. Ten of the cases were found to be unresectable at the stage of laparotomy. Median follow-up was 41.3 (24.8–57.9) months. Overall survival rate for all 35 patients was 56.4% at 1 year, 32.2% at 2 years, and 16.1% at 3 years. When survivals were compared according to operation type, 1, 2, and 3-year survivals were 80%, 57.1% and 42.9% for the hepatectomy group; 55.6%, 44.4% and 11.1% for the EHBD resection group; 75%, 0% and 0% in laparotomy-only group, respectively (p = 0.13). The best survival rates were obtained in patients with pCCA who underwent hepatectomy and were lymph node negative, 100% for 1 year, 66.7 for 2 years and 50% for 3 years. It is difficult to achieve high survival rates in BC type IV pCCA. However, these patients mostly benefit from resective treatments. Acceptable survival rates can be achieved, especially in the R0N0 patient group.
- 23 May 2022
- Published by Taylor & Francis in Acta Chirurgica Belgica
- Vol. 123 (5) , 1-8
Critical overview of resection for Bismuth-Corlette type IV perihilar cholangiocarcinoma
Current standard treatment for perihilar cholangiocarcinoma (pCCA) is surgical resection. Bismuth-Corlette (BC) type IV pCCA is accepted as an unresectable disease. In the present study, the results of non-transplant surgical approaches in patients with BC type IV pCCA were examined. Medical records of consecutive patients with BC type IV pCCA between 2010 and 2021 were retrospectively reviewed. Patients were subdivided according to operation type. Postoperative survival rates were compared. Hemihepatectomy with caudate lobe and extrahepatic bile duct (EHBD) resection was performed in 15 patients and only EHBD resection was performed in 10 patients. Ten of the cases were found to be unresectable at the stage of laparotomy. Median follow-up was 41.3 (24.8–57.9) months. Overall survival rate for all 35 patients was 56.4% at 1 year, 32.2% at 2 years, and 16.1% at 3 years. When survivals were compared according to operation type, 1, 2, and 3-year survivals were 80%, 57.1% and 42.9% for the hepatectomy group; 55.6%, 44.4% and 11.1% for the EHBD resection group; 75%, 0% and 0% in laparotomy-only group, respectively (p = 0.13). The best survival rates were obtained in patients with pCCA who underwent hepatectomy and were lymph node negative, 100% for 1 year, 66.7 for 2 years and 50% for 3 years. It is difficult to achieve high survival rates in BC type IV pCCA. However, these patients mostly benefit from resective treatments. Acceptable survival rates can be achieved, especially in the R0N0 patient group.